Cohera Medical wins approvable letter from FDA for TissuGlu surgical sealant

Cohera Medical says the FDA sent it an 'approvable letter' for its TissuGlu surgical sealant, clearing the way for pre-market approval in a few weeks.

Cohera Medical today said it received an "approvable letter" from the FDA for its TissuGlu surgical sealant, noting that it expects to win pre-market approval "within a few weeks."

Cohera Medical Inc., Food & Drug Administration (FDA)

News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Surgical

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1AAEMvt